Search Results 491-500 of 17413 for atrial fibrillation
Hyoscyamine for a Slow Ventricular Response During Atrial Fibrillation. Ann Intern Med 2019 May 21; 170 (10):735. View PubMed; Helgeson SA, Mwakyanjala EJ ...
... atrial fibrillation: cluster randomized controlled trial. BMJ. 2025 Jan 9; 388:e079976 Epub 2025 Jan 09. View PubMed; Toro-Tobon D, Singh Ospina N, Brito JP ...
... atrial fibrillation undergoing clinically indicated implantation or replacement of cardiovascular implantable electrical devices. ... The purpose of this study is ...
Cardiomyopathy; Coronary artery disease; Palpitations; Atrial fibrillation; Hypertension; Syncope (passing out symptoms); Valvular Heart Disease. Conditions ...
Learn more about atrial fibrillation. · Explore the Division of Cardiovascular Diseases. · Connect with others talking about A-Fib and heart health on Mayo Clinic ...
These patients had atrial fibrillation and started taking oral anticoagulants ─ apixaban, dabigatran, rivaroxaban or warfarin ─ sometime between Oct. 1, 2010, ...
Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality. Am J Cardiol. 2018 Jan 1; 121 (1):41-49 Epub 2017 ...
... atrial fibrillation and sudden cardiac death. He is particularly focused on clinical electrophysiology for older adults. Dr. Shen's research program is ...
... Atrial Fibrillation. J Cardiovasc Electrophysiol. 2025 Aug; 36 (8):1826-1835 ... atrial fibrillation: insights from a retrospective cohort study. Eur J ...
For decades, warfarin was the only available oral anticoagulant and the mainstay for reducing the risk of stroke in nonvalvular atrial fibrillation. But ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.